Traditional chinese medicine composition for adjuvant therapy in middle stage of novel coronavirus infection and preparation method of traditional chinese medicine composition

The invention provides a traditional chinese medicine composition for adjuvant therapy in the middle stage of novel coronavirus infection. The composition is prepared from the following raw materialsof, in parts by weight, 1-30 parts of radix puerariae, 1-10 parts of fructus gardeniae, 1-15 parts of honeysuckle, 2-30 parts of houttuynia cordata, 1-20 parts of hippophae rhamnoides leaves, 1-15 parts of perillaseed, 1-12 parts of apricot kernels, 1-10 parts of peach kernels, 1-10 parts of platycodon grandiflorum and 1-10 parts of green tea. The invention further provides a preparation method ofthe traditional chinese medicine composition for adjuvant therapy in the middle stage of novel coronavirus infection. According to the traditional chinese medicine composition for adjuvant therapy inthe middle stage of novel coronavirus infection, the research result of a formula component, target spot and pharmacological action mechanism network is consistent with specialities, and the composition conforms to the modern precision medical principle; and meanwhile, the composition is low in cost and meets the requirement of industrial production.